Potentially effective drugs for the treatment of COVID-19 or MIS-C in children: a systematic review
2022 · European Journal of Pediatrics · 28 citations
https://doi.org/10.1007/s00431-022-04388-w
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
195
Citations
6
h-index
3
i10-index
Shuai Peng is an academic researcher from Guangxi Medical University. The author has contributed to research in topics: COVID-19 Clinical Research Studies & Lung Cancer Diagnosis and Treatment & Mechanical Circulatory Support Devices. The author has an h-index of 6, co-authored 18 publications.
ORCID: 0000-0002-7107-3587https://doi.org/10.1007/s00431-022-04388-w
https://doi.org/10.1177/00368504251318196
Click to start Chat